All SEC Filings :: Acurx Pharmaceuticals, Inc. (ACXP)

Filing Type:

Year:

Date	Form	Description	PDF	XBRL	Pages
06/22/21	CORRESP	A correspondence can be sent as a document with another submission type or can be sent as a separate submission.			1
06/11/21	FWP	Filing under Securities Act Rules 163/433 of free writing prospectuses			22
06/11/21	S-1/A	General form of registration statement for all companies including face-amount certificate companies Documents EX-1.1 EX-5.1			179
05/27/21	S-1	General form of registration statement for all companies including face-amount certificate companies Documents EX-1.1 EX-2.1 EX-3.1 EX-3.2 EX-3.3 EX-4.1 EX-5.1 EX-10.1 EX-10.2 EX-10.3 EX-10.4 EX-10.5 EX-10.6 EX-10.7 EX-10.8 EX-10.9 EX-10.10 EX-10.11 EX-23.1 EX-99.1 EX-99.2 EX-99.3 EX-99.4			304
05/26/21	CORRESP	A correspondence can be sent as a document with another submission type or can be sent as a separate submission.			1
05/21/21	UPLOAD	SEC-generated letter Documents TEXT-EXTRACT			2
05/10/21	DRSLTR	Correspondence Related to Draft Registration Statement			4
05/10/21	DRS/A	Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy Documents EX-2.1 EX-3.1 EX-3.2 EX-3.3 EX-10.1 EX-10.2 EX-10.3 EX-10.5 EX-10.10 EX-10.11 EX-99.1 EX-99.2 EX-99.3 EX-99.4			235
04/30/21	UPLOAD	SEC-generated letter Documents TEXT-EXTRACT			5
04/05/21	DRS	Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy			134

8
9
10
11
12
13
14
15
16
17